Primary Excision Margins and Sentinel Lymph Node Biopsy in Clinically Node-negative Melanoma of the Trunk or Extremities

2010 Browman, 1995, The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation, J Clin Oncol, 13, 502, 10.1200/JCO.1995.13.2.502 2003 2006 2007 2008 Lens, 2007, Excision margins for primary cutaneous melanoma. Updated pooled analysis of randomized controlled trials, Arch Surg, 142, 885, 10.1001/archsurg.142.9.885 Sladden, 2009, Surgical excision margins for primary cutaneous melanoma, Cochrane Database Syst Rev, 10.1002/14651858.CD004835.pub2 Leiter, 2010, Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement, Ann Surg Oncol, 17, 129, 10.1245/s10434-009-0780-2 Lens, 2002, Excision margins in the treatment of primary cutaneous melanoma: a systematic review of randomized controlled trials comparing narrow vs wide excision, Arch Surg, 137, 1101, 10.1001/archsurg.137.10.1101 Haigh, 2003, Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis, Can J Surg, 46, 419 Veronesi, 1991, Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma, Arch Surg, 126, 438, 10.1001/archsurg.1991.01410280036004 Balch, 2001, Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1–4 mm melanomas, Ann Surg Oncol, 8, 101 Cohn-Cedermark, 2000, Long term results of a randomized study by the Swedish Melanoma Study Group on 2-cm versus 5-cm resection margins for patients with cutaneous melanoma with a tumor thickness of 0.8–2.0 mm, Cancer, 89, 1495, 10.1002/1097-0142(20001001)89:7<1495::AID-CNCR12>3.0.CO;2-D Khayat, 2003, Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick), Cancer, 97, 1941, 10.1002/cncr.11272 Thomas, 2004, Excision margins in high-risk malignant melanoma, N Engl J Med, 350, 757, 10.1056/NEJMoa030681 Sladden, 2004, Surgical excision margins for localised cutaneous melanoma [intervention protocol], Cochrane Database Syst Rev, 10.1002/14651858.CD004835 Srigley, 2009, Standardized synoptic cancer pathology reporting: a population-based approach, J Surg Oncol, 99, 517, 10.1002/jso.21282 Chambers, 2009, Improvement in the accuracy of reporting key prognostic and anatomic findings during thyroidectomy by using a novel web-based synoptic operative reporting system, Surgery, 146, 1090, 10.1016/j.surg.2009.09.032 Karim, 2008, The advantage of using a synoptic pathology report format for cutaneous melanoma, Histopathology, 52, 130, 10.1111/j.1365-2559.2007.02921.x Balch, 2001, Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system, J Clin Oncol, 19, 3622, 10.1200/JCO.2001.19.16.3622 Morton, 2006, Sentinel-node biopsy or nodal observation in melanoma, N Eng J Med, 355, 1307, 10.1056/NEJMoa060992 Balch, 2010, Multivariate analysis of prognostic factors among 2313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases, J Clin Oncol, 28, 2452, 10.1200/JCO.2009.27.1627 Balch, 2009, Final version of 2009 AJCC melanoma staging and classification, J Clin Oncol, 27, 6199, 10.1200/JCO.2009.23.4799 Thomas, 2006, Time for comprehensive reporting of MSLT-1, Lancet Oncol, 7, 9, 10.1016/S1470-2045(05)70518-0 Grichnik, 2007, Sentinel-node biopsy in melanoma, N Engl J Med, 356, 418, 10.1056/NEJMc062965 Gershenwald, 2007, Is sentinel-node biopsy superior to nodal observation in melanoma?: commentary, Natl Clin Pract Oncol, 4, 278, 10.1038/ncponc0791 Gonzalez, 2007, Cloud of sentinel node biopsy: unlikely survival benefit in melanoma, Arch Dermatol, 143, 775, 10.1001/archderm.143.6.775 Calabro, 1989, Patterns of relapse in 1001 consecutive patients with melanoma nodal metastases, Arch Surg, 124, 1051, 10.1001/archsurg.1989.01410090061014 Henderson, 2009, Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: results of an intergroup randomized trial (ANZMTG 01.01/TROG 02.01), J Clin Oncol, 27, 10.1200/jco.2009.27.18s.lba9084 Morton, 1992, Technical details of intraoperative lymphatic mapping for early stage melanoma, Arch Surg, 127, 392, 10.1001/archsurg.1992.01420040034005 Jansen, 2000, Reliability of sentinel lymph node biopsy for staging melanoma, Br J Surg, 87, 484, 10.1046/j.1365-2168.2000.01362.x Estourgie, 2003, Review and evaluation of sentinel node procedures in 250 melanoma patients with a median follow-up of 6 years, Ann Surg Oncol, 10, 681, 10.1245/ASO.2003.01.023 Morton, 2005, Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-1, an international multicenter trial, Ann Surg, 242, 302, 10.1097/01.sla.0000181092.50141.fa Kretschmer, 2008, Postoperative morbidity of lymph node excision for cutaneous melanoma-sentinel lymphonodectomy versus complete regional lymph node dissection, Melanoma Res, 18, 16, 10.1097/CMR.0b013e3282f2017d Roulin, 2008, Prognostic value of sentinel node biopsy in 327 prospective melanoma patients from a single institution, Eur J Surg Oncol, 34, 673, 10.1016/j.ejso.2007.07.197 McMasters, 2004, Lessons learned from the Sunbelt melanoma trial, J Surg Oncol, 86, 212, 10.1002/jso.20084 Warycha, 2009, Meta-analysis of sentinel lymph node positivity in thin melanoma (≤1 mm), Cancer, 115, 869, 10.1002/cncr.24044 Kirkwood, 2001, High-dose interferon alfa-2b significantly prolongs relapse-free and overall survival compared with the GM2-KLH/QS-21 vaccine in patients with resected stage IIB-III melanoma: results of Intergroup trial E1694/S9512/C509801, J Clin Oncol, 19, 2370, 10.1200/JCO.2001.19.9.2370 Eggermont, 2008, Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial, Lancet, 372, 117, 10.1016/S0140-6736(08)61033-8